Table 3

Agreement with statements on the components of screening at birth and in childhood in rounds 1 and 2
Statement R1 N R1 % Agree(IQD) R2 % Agree(IQD)
Screening at birth
1. prenatal alcohol exposure 92 98 (1) -
2. birth weight, length and head circumference 90 100 (1) -
3. fatty acid esters (FAEE) in meconium collected within 72 hours of birth 37 46 (3) -
4. characteristic FAS facial anomalies 89 98 (1) -
5. birth defects 89 98 (1) -
6. evidence of withdrawal from alcohol or other drugs 90 99 (1) -
7. family history of FASD or developmental delay 79 - 95 (1)
8. evidence of CNS dysfunction including irritability, feeding difficulties or other neurological signs 77 91 (1)
9. most of the information required for FASD screening at birth is routinely collected at birth 72 - 56 (2)
10. screening for FASD at birth primarily requires health professionals to assess prenatal alcohol exposure and consider it as a potential cause of other relevant abnormalities identified 79 - 86 (1)
11. a checklist is needed to support the implementation of screening for FASD at birth that identifies the components to be assessed and criteria for conducting a full diagnostic evaluation 79 - 84 (1)
Screening in childhood
12. prenatal alcohol exposure 90 97 (1) -
13. growth (height and weight) 89 98 (1) -
14. head circumference 86 99 (1) -
15. developmental delay 89 99 (1) -
16. neurological signs 87 93 (1) -
17. functional CNS abnormalities (e.g. cognition, behaviour disorders) 88 99 (1) -
18.hearing and vision 85 93 (1) -
19. characteristic FAS facial anomalies 89 98 (1) -
20. birth defects 89 97 (1) -
21. family history of FASD, developmental delay, abuse or neglect 78 - 97 (1)
22. most of the information required for FASD screening in childhood is routinely assessed as part of a general clinical assessment of children with neurodevelopmental or other related presentations 71 - 59 (2)
23. screening for FASD in childhood primarily requires health professionals to assess prenatal alcohol exposure and consider it as a potential cause of other relevant abnormalities identified (e.g. abnormalities of development, learning, behaviour) 77 - 88 (1)
24. a checklist is needed to support the implementation of screening for FASD in childhood that identifies the components to be assessed and criteria for conducting a full diagnostic evaluation 78 - 90 (1)

R1-Round 1; R2-Round 2; IQD-inter-quartile deviation; CNS-central nervous system.

Includes responses ‘agree’ and ‘strongly agree.’

Results for statements that reached 70% agreement (consensus) are presented in bold.

Watkins et al.

Watkins et al. BMC Pediatrics 2013 13:13   doi:10.1186/1471-2431-13-13

Open Data